ArticleBone & joint open2026
Long-term results of the modified Dunn procedure in slipped capital femoral epiphysis : a minimum of ten-year follow-up.
Article in Bone & joint open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: In situ fixation for slipped capital femoral epiphysis (SCFE) prevents further displacement, but fails to correct the proximal femoral deformity, which may lead to femoroacetabular impingement (FAI) and early osteoarthritis (OA). The modified Dunn procedure (MDP) restores proximal femoral anatomy with the aim of improving long-term joint preservation. However, evidence beyond mid-term follow-up remains limited. This study evaluates the ten-year survivorship, functional outcomes, and radiological correction following MDP. Methods: A retrospective single-centre review was performed of patients treated with the MDP between 2007 and 2014 for stable or unstable SCFE of any severity. Patients with preoperative avascular necrosis (AVN) were excluded. Primary outcomes were ten-year survivorship free from conversion to total hip arthroplasty (THA) and from radiological OA progression (≥ 1 Tönnis grade). Secondary outcomes included patient-reported outcome measures, hip range of motion, clinical signs of FAI, and correction of the Southwick and α angles. Kaplan-Meier survival analyses were performed and stratified by slip severity. Results: A total of 35 hips (34 patients) completed ≥ ten years of follow-up (163 months (SD 34)). Ten-year THA conversion-free survivorship was 88.6%, decreasing from 100% in mild slips to 86.4% in moderate and 83.3% in severe slips. Ten-year OA progression-free survivorship was 82.9%, with rates of 100%, 81.8%, and 66.7% for mild, moderate, and severe slips, respectively. The mean ten-year functional scores were high (modified Harris Hip Score 88.9 (SD 4.4); University of California, Los Angeles Activity Scale 8.9 (SD 1.6); and Merle d'Aubigné-Postel 17.7 (SD 0.9)). Substantial radiological correction was observed, with the Southwick angle improving from 45.0° to 13.1° and the α angle from 85.8° to 50.9°. No postoperative AVN occurred. Conclusion: At ten-year follow-up, the MDP achieved excellent functional outcomes and effective deformity correction in SCFE, with high survivorship in mild and moderate slips. However, progression of hip OA was less favourable in severe slips.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.